Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)

Diffuse large B cell lymphoma (DLBCL) is clinically and biologically heterogeneous. In most cases of DLBCL, lymphoma cells coexpress vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2, suggesting autocrine in addition to angiogenic effects. We enumerated microvessel densit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gratzinger, Dita, Advani, Ranjana, Zhao, Shuchun, Talreja, Neha, Tibshirani, Robert J., Shyam, Ragini, Horning, Sandra, Sehn, Laurie H., Farinha, Pedro, Briones, Javier, Lossos, Izidore S., Gascoyne, Randy D., Natkunam, Yasodha
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809124/
https://ncbi.nlm.nih.gov/pubmed/19821819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07942.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares